234 related articles for article (PubMed ID: 26810408)
21. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
22. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
23. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
24. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
[TBL] [Abstract][Full Text] [Related]
25. Advances in Radiation Oncology for the Treatment of Cervical Cancer.
Faye MD; Alfieri J
Curr Oncol; 2022 Feb; 29(2):928-944. PubMed ID: 35200578
[TBL] [Abstract][Full Text] [Related]
26. Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer.
Cengiz M; Dogan A; Ozyigit G; Erturk E; Yildiz F; Selek U; Ulger S; Colak F; Zorlu F
Brachytherapy; 2012; 11(2):125-9. PubMed ID: 22192496
[TBL] [Abstract][Full Text] [Related]
27. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
[TBL] [Abstract][Full Text] [Related]
28. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer.
Miglietta L; Franzone P; Centurioni MG; Boni L; Tacchini L; Cosso M; Boccardo F; Ferrarini M; Bruzzone M
Oncology; 2006; 70(1):19-24. PubMed ID: 16439862
[TBL] [Abstract][Full Text] [Related]
29. Should helical tomotherapy replace brachytherapy for cervical cancer? Case report.
Hsieh CH; Wei MC; Hsu YP; Chong NS; Chen YJ; Hsiao SM; Hsieh YP; Wang LY; Shueng PW
BMC Cancer; 2010 Nov; 10():637. PubMed ID: 21092235
[TBL] [Abstract][Full Text] [Related]
30. Patterns of care and impact of brachytherapy boost utilization for squamous cell carcinoma of the base of tongue in a large, national cohort.
Lee A; Givi B; Wu SP; Tam MM; Gerber NK; Hu KS; Han P; Schreiber D
Brachytherapy; 2017; 16(6):1205-1212. PubMed ID: 28943128
[TBL] [Abstract][Full Text] [Related]
31. High-dose-rate interstitial brachytherapy with computed tomography-based treatment planning for patients with locally advanced uterine cervical carcinoma.
Saitoh J; Ohno T; Sakurai H; Katoh H; Wakatsuki M; Noda SE; Suzuki Y; Sibuya K; Takahashi T; Nakano T
J Radiat Res; 2011; 52(4):490-5. PubMed ID: 21785237
[TBL] [Abstract][Full Text] [Related]
32. Treatment optimization with concurrent SBRT and intracavitary brachytherapy for locally advanced cervical cancer.
Wan B; Lang J; Wang P; Ma CM
J Appl Clin Med Phys; 2016 Jan; 17(1):70-79. PubMed ID: 26894333
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy.
Facondo G; Vullo G; DE Sanctis V; Valeriani M; Ascolese AM; Massaro M; Anzellini D; Osti MF
Cancer Diagn Progn; 2021; 1(2):53-60. PubMed ID: 35403131
[TBL] [Abstract][Full Text] [Related]
34. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
35. CyberKnife Boost for Patients with Cervical Cancer Unable to Undergo Brachytherapy.
Haas JA; Witten MR; Clancey O; Episcopia K; Accordino D; Chalas E
Front Oncol; 2012; 2():25. PubMed ID: 22655266
[TBL] [Abstract][Full Text] [Related]
36. Dose escalation by intensity-modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease.
Khosla D; Patel FD; Rai B; Chakraborty S; Oinam AS; Sharma SC
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):e1-6. PubMed ID: 22889568
[TBL] [Abstract][Full Text] [Related]
37. Results of postoperative radiation therapy for patients with carcinoma of the uterine cervix: evaluation of intravaginal cone boost with an electron beam.
Mitsuhashi N; Takahashi M; Yamakawa M; Nozaki M; Takahashi T; Sakurai H; Maebayashi K; Hayakawa K; Niibe H
Gynecol Oncol; 1995 Jun; 57(3):321-6. PubMed ID: 7774835
[TBL] [Abstract][Full Text] [Related]
38. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
Chen CC; Lin JC; Jan JS; Ho SC; Wang L
Gynecol Oncol; 2011 Jul; 122(1):9-13. PubMed ID: 21514629
[TBL] [Abstract][Full Text] [Related]
39. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
40. [Can stereotactic body radiotherapy replace brachytherapy for locally advanced cervical cancer? French society for radiation oncology statement].
Chargari C; Renard S; Espenel S; Escande A; Buchheit I; Ducassou A; Peiffert D; Hannoun-Lévi JM
Cancer Radiother; 2020 Oct; 24(6-7):706-713. PubMed ID: 32753238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
